Profilo
Attualmente, Kimi E. Iguchi occupa la posizione di direttore finanziario e tesoriere presso SAGE Therapeutics, Inc. La signora Iguchi è anche nel consiglio di amministrazione di Disarm Therapeutics, Inc. In precedenza è stata vicepresidente finanziario di Cyberkinetics Neurotechnology Systems, Inc., direttore operativo della regione Nord America presso Santhera Pharmaceuticals Holding AG, Senior Manager-External Reporting presso Biogen, Inc. e direttore finanziario presso Biogen MA, Inc. (una filiale di Biogen, Inc.), Senior Director-Finance, Reporting & Analysis presso Millennium Pharmaceuticals, Inc. e Manager-Business Assurance presso PricewaterhouseCoopers LLP. La signora Iguchi si è laureata alla Drew University e ha conseguito un MBA alla Northeastern University.
Posizioni attive di Kimi Iguchi
| Società | Posizione | Inizio |
|---|---|---|
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat patients with neurological diseases | Direttore/Membro del Consiglio | 25/10/2018 |
Precedenti posizioni note di Kimi Iguchi
| Società | Posizione | Fine |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Direttore Finanziario/CFO | 31/10/2024 |
| SANTHERA PHARMACEUTICALS HOLDING AG | Corporate Officer/Principal | 01/09/2011 |
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Direttore Finanziario/CFO | 31/05/2007 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/1998 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Corporate Officer/Principal | 01/01/1995 |
Formazione di Kimi Iguchi
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Drew University
Drew University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAGE Therapeutics, Inc.
SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat patients with neurological diseases | Health Technology |
















